Lama/laba Glycopyrrolate/formoterol Fixed-Dose Combination, Delivered Using A Novel Mdi Co-Suspension (TM) Delivery Technology Reduces Risk Of Clinically Important Deteriorations In COPD Versus Placebo And Monocomponent Mdis
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要